Detalhe da pesquisa
1.
Inflammation, mitochondrial dysfunction and physical performance: a possible association in older patients with persistent atrial fibrillation-the results of a preliminary study.
Aging Clin Exp Res
; 35(11): 2831-2837, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733227
2.
The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.
Int J Cancer
; 151(12): 2265-2277, 2022 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054818
3.
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
J Nanobiotechnology
; 18(1): 31, 2020 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066449
4.
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.
Blood
; 118(8): 2254-65, 2011 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21734236
5.
The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors.
Front Immunol
; 14: 1236824, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936683
6.
Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses.
Immunol Invest
; 41(6-7): 722-37, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23017143
7.
Magnetic Resonance Imaging Correlates of Immune Microenvironment in Glioblastoma.
Front Oncol
; 12: 823812, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392230
8.
Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients.
Front Immunol
; 12: 809826, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35069595
9.
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade.
Front Immunol
; 11: 1590, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32793228
10.
Baricitinib restrains the immune dysregulation in patients with severe COVID-19.
J Clin Invest
; 130(12): 6409-6416, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32809969
11.
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo.
Curr Protoc Immunol
; 124(1): e61, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303619
12.
The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion.
J Immunother Cancer
; 7(1): 58, 2019 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30813960
13.
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
J Immunother Cancer
; 7(1): 255, 2019 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31533831
14.
Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma.
Oncoimmunology
; 7(7): e1440931, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29900047
15.
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.
Biomaterials
; 96: 47-62, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27135716
16.
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.
Oncotarget
; 7(2): 1168-84, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26700461
17.
Longitudinal evolution of the immune suppressive glioma microenvironment in different synchronous lesions during treatment.
Neurooncol Adv
; 2(1): vdz053, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32642721
18.
Complexity and challenges in defining myeloid-derived suppressor cells.
Cytometry B Clin Cytom
; 88(2): 77-91, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25504825
19.
Complexity and challenges in defining myeloid-derived suppressor cells.
Cytometry B Clin Cytom
; 2014 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425222
20.
Myeloid-derived suppressor cell heterogeneity in human cancers.
Ann N Y Acad Sci
; 1319: 47-65, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965257